Neurotoxicity secondary to antineoplastic drugs.
Tuxen
M K
MK
Department of Oncology, Herlev University Hospital, Denmark.
Hansen
S W
SW
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002490:Central Nervous System / Q000187:drug effects; D002945:Cisplatin / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009420:Nervous System / Q000187:drug effects*; D014748:Vinca Alkaloids / Q000009:adverse effects
D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D003561:Cytarabine; D002945:Cisplatin; D005472:Fluorouracil; D007069:Ifosfamide; D008727:Methotrexate